FINWIRES · TerminalLIVE
FINWIRES

$TMO

28 stories mentioning TMO

Every FINWIRES story that references TMO, newest first.

US Markets

Thermo Fisher Raises 2026 Outlook Despite First-Quarter Organic Revenue Growth Miss

Thermo Fisher Scientific (TMO) raised its full-year outlook on Thursday as first-quarter results came in stronger than expected, even as organic growth fell short of analysts' estimates.The medical-device manufacturer now expects 2026 adjusted per-share earnings of $24.64 to $25.12, indicating an increase of 8% to 10% from the year prior, compared with the previous guidance of $24.22 to $24.80, CEO Marc Casper said during an earnings call, according to a FactSet transcript. Analysts on FactSet are looking for full-year non-GAAP EPS of $24.66.Full-year revenue outlook is now pegged at $47.3 billion to $48.1 billion, representing a 6% to 8% growth year over year, up from the previous guidance range of $46.3 billion to $47.2 billion, Casper said. The Wall Street consensus is for revenue of $47.09 billion. Casper said the updated estimates continue to assume a 3% to 4% organic revenue growth for the year."We are raising our guidance for the full year on the top and bottom line, incorporating the positive impact of (Clario Holdings) and the strong first-quarter earnings performance," Casper said, referring to the provider of endpoint data solutions for clinical trials, which Thermo Fisher recently acquired.In the three months ended March 28, adjusted EPS rose to $5.44 from $5.15 a year earlier and surpassed the FactSet consensus of $5.25. Revenue grew 6% to $11.01 billion, while analysts expected $10.86 billion.The company logged organic growth of 1%, trailing the consensus for a 1.3% improvement. The stock fell 7.6% in Thursday trading and has dropped 18% this year.Revenue in the life sciences solutions segment in the first quarter rose to $2.64 billion from $2.34 billion a year earlier, exceeding the consensus of $2.60 billion. Sales in the analytical instruments division were $1.72 billion, while analysts expected $1.73 billion. Laboratory products and biopharma services revenue climbed to $6.04 billion from $5.46 billion."Our end markets and our business are progressing in line with our expectations, and we're on track to deliver a strong year," Casper said.Chief Financial Officer Jim Meyer said adjusted EPS in the current quarter is expected to be $0.25 to $0.30 higher than the first quarter. Analysts expected $5.82.Price: $474.71, Change: $-39.27, Percent Change: -7.64%

$TMO
Sectors

Sector Update: Health Care Stocks Decline Premarket Thursday

Health care stocks were declining premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.3% and the iShares Biotechnology ETF (IBB) 0.7% lower.Thermo Fisher Scientific (TMO) stock was down more than 9% even after the company posted higher fiscal Q1 adjusted earnings and revenue.Sanofi (SNY) shares were up more than 3% after the company reported higher Q1 adjusted earnings and net sales.West Pharmaceutical Services (WST) stock was up more than 16% after the company reported higher Q1 non-GAAP earnings and net sales. West Pharmaceutical Services also issued Q2 outlook above analysts' expectations and raised its 2026 guidance.

$IBB$SNY$TMO$WST$XLV
Asia Markets

US Equity Futures Decline Pre-Bell as Investors Turned Wary Amid Stalled US-Iran Peace Talks

US equity futures were lower pre-bell Thursday as the market turned wary amid the lack of clarity regarding the Middle East situation, with peace talks stalled indefinitely after President Donald Trump extended the ceasefire.Dow Jones Industrial Average futures were 0.4% lower, S&P 500 futures were down 0.2%, and Nasdaq futures were 0.1% lower.Iran said Wednesday it had captured two container vessels in the Strait of Hormuz, while the US is maintaining its blockade of Iranian ports.Trump has said that the ceasefire is extended until Iran's "fractured" government can come up with a unified proposal regarding the end of the conflict.Traders took note of today's round of earnings, with American Express (AXP) posting higher Q1 earnings and revenue and Thermo Fisher Scientific (TMO) reporting increases in fiscal Q1 adjusted earnings and revenue. Intel (INTC) and SAP (SAP) are set to report their results after market close.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 0.2% at $101.72 per barrel and US West Texas Intermediate crude 0.2% higher at $92.77 per barrel.Initial jobless claims rose to a level of 214,000 in the employment survey week ended April 18 from an upwardly revised 208,000 level in the previous week, compared with expectations for an increase to 210,000 in survey of analysts compiled by Bloomberg.The Chicago Fed National Activity Index came in at negative 0.20 in March, compared with expectations for negative 0.13 and down from 0.03 in the prior month.The April S&P Global Composite Purchasing Managers' Index, due at 9:45 am ET, is seen coming in at 50.6.In other world markets, Japan's Nikkei closed 0.8% lower, Hong Kong's Hang Seng ended 1% lower, and China's Shanghai Composite finished 0.3% lower. Meanwhile, the UK's FTSE 100 was down 0.6%, and Germany's DAX index was 0.2% lower in Europe's early afternoon session.In equities, IBM (IBM) shares were down 7.9% despite posting late Wednesday Q1 adjusted earnings and revenue. Tesla (TSLA) stock was 3.3% lower after the company issued higher-than-expected 2026 capital expenditure guidance for 2026. Thermo Fisher Scientific shares were down 7.1% after the company posted its Q1 financial results.On the winning side, Texas Instruments (TXN) shares were up 11% after the company posted higher Q1 earnings and revenue in addition to issuing Q2 guidance that exceeded analyst expectations. Netflix (NFLX) stock was up by 1.2% after Bloomberg reported that the company was is in talks to purchase a historic Los Angeles movie studio space for a fragment of its 2021 sale price of $1.85 billion. The company also said it authorized an additional $25 billion share repurchase program.

Dow JonesNasdaq CompositeS&P 500$AXP$IBM$INTC$NFLX$SAP$TMO$TSLA$TXN
Sectors

Sector Update: Health Care

Health care stocks were declining premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) 0.5% lower.Thermo Fisher Scientific (TMO) stock was down more than 7% even after the company posted higher fiscal Q1 adjusted earnings and revenue.

$TMO
Research

Research Alert: Thermo Fisher Scientific: Q1 Results Top Estimates As Clario Acquisition Closes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:TMO delivered Q1 top- and bottom-line beats with adjusted EPS of $5.44 vs. the $5.15 consensus and revenue of $11.01B (+6% Y/Y), though organic growth remained modest at 1% as the $8.9B Clario acquisition contributed significantly to performance. Mixed segment performance showed Life Sciences Solutions strength at $2.64B (+13% Y/Y) with improved 36.2% margin benefiting from the Solventum acquisition, while Analytical Instruments faced flat revenue and significant margin compression to 20.7% from 23.2% the prior year reflecting ongoing equipment spending pressures. FCF surged to $825M from $373M, supporting return of capital to shareholders. TMO returned $3.0B through share repurchases and increased its dividend 10%. The company plans to update 2026 financial guidance during the upcoming earnings call. We believe the robust cash flow performance and disciplined capital allocation activities support TMO's operational resilience despite the challenging life sciences tools operating environment.

$TMO
Japan

US Equity Futures Drop as Investors Cautious Amid Stalled US-Iran Peace Talks

US equity futures were lower pre-bell on Thursday as the market turned wary on the lack of clarity regarding the Middle East situation, with peace talks stalled indefinitely after President Donald Trump extended the ceasefire.Dow Jones Industrial Average futures were 0.6% lower, S&P 500 futures were down 0.3%, and Nasdaq futures were 0.3% lower.Iran said Wednesday it had captured two container vessels in the Strait of Hormuz, while the US is maintaining its blockade of Iranian ports.Trump has said that the ceasefire is extended until Iran's "fractured" government can come up with a unified proposal regarding the end of the conflict.Traders took note of today's round of earnings, with American Express (AXP) posting higher Q1 earnings and revenue and Thermo Fisher Scientific (TMO) posting increases in fiscal Q1 adjusted earnings and revenue. Intel (INTC) and SAP (SAP) are set to report their results after-market.Oil prices were higher, with front-month global benchmark North Sea Brent crude up 0.7% at $102.61 per barrel and US West Texas Intermediate crude 0.6% higher at $93.55 per barrel.Initial jobless claims are projected to have increased to 210,000 in the week ended April 18 from 207,000 the prior week, according to estimates compiled by Bloomberg.The Chicago Fed National Activity Index, due at 8:30 am ET, is seen coming in at negative 0.13 in March, compared with negative 0.11 in the prior month.The April S&P Global Composite Purchasing Managers' Index, due at 9:45 am ET, is seen coming in at 50.6.

Dow JonesNasdaq CompositeS&P 500$AXP$INTC$SAP$TMO
US Markets

Stocks Fall Pre-Bell as US-Iran Peace Talks Stall; Traders Parse Tesla's Results

US equity futures were tracking in the red on Thursday, with no apparent signs of progress in peace talks between the US and Iran, while traders digest Tesla's (TSLA) latest financial results.The S&P 500 and the Nasdaq declined 0.6% each in premarket activity, while the Dow Jones Industrial Average was off 0.7%. The indexes finished Wednesday trading in the green, with the S&P 500 and the Nasdaq hitting record highs after a two-day losing streak.Washington and Tehran have so far failed to meet for a reported fresh round of negotiations this week, with Iran continuing its blockade of the Strait of Hormuz. US Vice President JD Vance called off his trip to Pakistan for the talks after Iran reportedly declined to participate.President Donald Trump extended a ceasefire with Iran earlier in the week, though he said the naval blockade of Iranian ports would continue. Iran's Islamic Revolutionary Guard Corps on Wednesday reportedly announced the seizure of two tankers attempting to cross the Strait of Hormuz.West Texas Intermediate crude oil rose 1.8% to $94.60 a barrel before the open, while Brent gained 1.7% to $103.59."Oil prices continue to whipsaw as traders respond to a confusing and often contradictory flow of headlines, underscoring the deep mistrust between Tehran and Washington," Saxo Bank Head of Commodity Strategy Ole Hansen said in a report on Wednesday.Shares of Tesla (TSLA) decreased 3.3% pre-bell even though the electric vehicle manufacturer reported stronger-than-expected first-quarter results. The company expects capital expenditures of more than $25 billion for 2026, resulting in negative free cash flow for the rest of the year, Chief Financial Officer Vaibhav Taneja said during a late Wednesday conference call, according to a FactSet transcript."Tesla is morphing into a physical (artificial intelligence) stalwart," Wedbush Securities said in a Thursday client note. "The path is here and it requires more (capital expenditure)."ServiceNow (NOW) dropped 13% while International Business Machines (IBM) fell 7.1% following their latest quarterly results. Taiwan Semiconductor Manufacturing's (TSM) US-listed stock was down 1.4%.American Express (AXP), Thermo Fisher Scientific (TMO), Union Pacific (UNP), Honeywell International (HON), Lockheed Martin (LMT), Comcast (CMCSA), Infosys (INFY) and Keurig Dr Pepper (KDP) report their earnings before the bell, among others. Intel (INTC) is scheduled to release its results after the markets close.Thursday's economic calendar has the weekly jobless claims bulletin at 8:30 am ET, along with the Chicago Fed national activity index for March. The S&P Global's (SPGI) flash purchasing managers' index for April is out at 9:45 am, followed by the Kansas City Fed manufacturing index for the same month at 11 am.Treasury yields were moving upwards in premarket action, with the two-year rate advancing 2.5 basis points to 3.82% and the 10-year rate adding 2.7 basis points to 4.32%.Gold declined 1% to $4,707 per troy ounce, while bitcoin retreated 1.8% to $77,473.

Dow JonesNasdaq CompositeS&P 500$AXP$CMCSA$HON$IBM$INFY$INTC$KDP$LMT$NOW$SPGI$TMO$TSLA$UNP
Wire

AIM ImmunoTech Starts Late-Stage Trial of Ampligen in Pancreatic Cancer

AIM ImmunoTech (AIM) said Thursday it has begun a phase 3 clinical trial of its experimental drug Ampligen for pancreatic cancer, calling the move an important milestone supported by encouraging phase 2 results.The company recently signed an agreement with Thermo Fisher Scientific's (TMO) PPD clinical research unit to help design the phase 3 study.An ongoing phase 2 trial testing Ampligen with AstraZeneca's (AZN) immunotherapy durvalumab has shown early signs of improved progression-free survival and overall survival, along with a favorable safety profile, AIM said.Price: $0.57, Change: $+0.03, Percent Change: +5.35%

$AIM$AZN$TMO

Showing 21-28 of 28